Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
SFDA · 11 medicines · Historical list
Show all 11AEMPS · 4 medicines
Anvisa · 3 medicines
AIFA · 3 medicines
HALMED · 2 medicines
MS · 2 medicines · Historical list
HSA · 2 medicines
CBG-MEB · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
62 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Iopamidol | United States | 41%, 51%, 61% … | injectable | Marketed | Hainan Poly |
| Iopamidol | Brazil | Cancelled | Alko do Brasil Industria e Comercio Ltda | ||
| Iopamidol-200 | United States | 41% | injectable | Not marketed | Cook Imaging |
| Iopamidol-250 | United States | 51% | injectable | Not marketed | Cook Imaging |
| Iopamidol-300 | United States | 61% | injectable | Not marketed | Abbvie |
| Iopamidol-370 | United States | 76% | injectable | Not marketed | Cook Imaging |
| Iopamidol ADOH 408 mg/ml (200 mg jodium/ml), oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Adoh B.V. | |
| Iopamidol-200 in Plastic Container | United States | 41% | injectable | Not marketed | Hospira |
| Iopamidol-250 in Plastic Container | United States | 51% | injectable | Not marketed | Hospira |
| Iopamidol-300 in Plastic Container | United States | 61% | injectable | Not marketed | Hospira |
| Iopamidol-370 in Plastic Container | United States | 76% | injectable | Not marketed | Hospira |
| Iopamidol Injection USP | Canada | 76 % | Solution | Cancelled | Hospira Healthcare Ulc |
| Iopamidol Injection USP | Canada | 61 % | Solution | Cancelled | Hospira Healthcare Ulc |
| Isovue-200 | United States | 41% | injectable | Marketed | Bracco |
| Isovue-250 | United States | 51% | injectable | Marketed | Bracco |
| Isovue-300 | United States | 61% | injectable | Marketed | Bracco |
| Isovue-370 | United States | 76% | injectable | Marketed | Bracco |
| Isovue-M 200 | United States | 41% | injectable | Marketed | Bracco |
| Isovue-M 300 | United States | 61% | injectable | Marketed | Bracco |
| Isovue-128 | United States | 26% | injectable | Not marketed | Bracco |
| Iopamiro | Italy | Soluzione iniettabile | Authorised | Bracco Imaging S.P.A. | |
| Scanlux-300 | United States | 61% | injectable | Not marketed | Sanochemia Corp USA |
| Scanlux-370 | United States | 76% | injectable | Not marketed | Sanochemia Corp USA |
| Iopamiron | Brazil | Authorised | Bracco Imaging do Brasil Importação e Distribuição de Medicamentos Ltda | ||
| Iopasen | Italy | Soluzione iniettabile | Authorised | Industria Farmaceutica Galenica Senese S.R.L. |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, MS and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
